Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022

SELL
$16.0 - $45.99 $18.7 Million - $53.8 Million
-1,170,111 Closed
0 $0
Q1 2022

Apr 19, 2022

SELL
$33.17 - $46.98 $1.43 Million - $2.02 Million
-43,096 Reduced 3.55%
1,170,111 $52.5 Million
Q4 2021

Jan 28, 2022

SELL
$39.06 - $67.58 $33 Million - $57.1 Million
-844,660 Reduced 41.05%
1,213,207 $52 Million
Q3 2021

Nov 12, 2021

SELL
$60.13 - $77.6 $28.1 Million - $36.3 Million
-467,746 Reduced 18.52%
2,057,867 $137 Million
Q2 2021

Aug 05, 2021

SELL
$50.07 - $76.78 $3.59 Million - $5.5 Million
-71,675 Reduced 2.76%
2,525,613 $185 Million
Q1 2021

May 13, 2021

BUY
$58.92 - $97.33 $31.2 Million - $51.5 Million
528,696 Added 25.56%
2,597,288 $178 Million
Q4 2020

Feb 12, 2021

BUY
$43.6 - $73.05 $70.7 Million - $118 Million
1,620,867 Added 362.02%
2,068,592 $139 Million
Q3 2020

Oct 30, 2020

SELL
$38.47 - $52.03 $1 Million - $1.36 Million
-26,045 Reduced 5.5%
447,725 $23 Million
Q2 2020

Aug 11, 2020

BUY
$27.28 - $43.01 $6.91 Million - $10.9 Million
253,318 Added 114.91%
473,770 $17.9 Million
Q1 2020

May 14, 2020

BUY
$23.08 - $35.53 $333,229 - $512,982
14,438 Added 7.01%
220,452 $6.57 Million
Q4 2019

Jan 31, 2020

BUY
$15.74 - $35.04 $628,450 - $1.4 Million
39,927 Added 24.04%
206,014 $7.08 Million
Q3 2019

Nov 12, 2019

BUY
$18.09 - $27.92 $3 Million - $4.64 Million
166,087 New
166,087 $3.01 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $724M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.